We are live on ! Find out more
DNA.WS

Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS

Delisted

DNA.WS was delisted on the 3rd of September, 2024.

Back to rankings

Fund managers haven’t disclosed any holdings of DNA.WS yet.

DNA.WS Hedge Fund Activity: Q1 2026 in Review

1 of the 8,132 institutional investors tracked by Wall St. Rank reported a position in Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share (DNA.WS) for Q1 2026, worth a combined $0 — down 100% from $1 a quarter earlier.

Fund positioning in DNA.WS was balanced in Q1 2026: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share (DNA.WS) as of Q1 2026, unchanged from Q4 2025.
  • Funds reported $0 of Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share stock for Q1 2026, down 100% quarter-over-quarter.
  • 0 funds opened new Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share positions in Q1 2026 and 0 closed out.

Based on aggregated 13F filings for Q1 2026.